Consent for Use of Stored Patient Specimens for Future Testing

StatusActive, Not Recruiting
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 30000 to confirmed 17444
    • Site details revised at 63 of 63 sites
    v44
  2. Site contacts updated at 12 of 63 sitesv43
  3. Primary and study completion dates: Dec 31, 2023 to Dec 31, 2027v42
  4. Trial status: Active, Not Recruiting to Recruiting
    • Site details revised at 63 of 63 sites
    v41
  5. Start date: Mar 2002 to Feb 13, 2002v40
Show 38 earlier versionsHide 38 earlier versions
  1. Trial status: Recruiting to Active, Not Recruiting
    • Site details revised at 63 of 63 sites
    v39
  2. 3 versions Re-verified since Oct 16, 2018, no change to tracked fieldsv36-v38
  3. Primary and study completion dates: Dec 2018 to Dec 31, 2023v35
  4. Study sites: 68 to 63v34
  5. Primary and study completion dates: Dec 2016 to Dec 2018v33
  6. Enrollment target: 20000 to 30000v32
  7. 3 versions Re-verified since Jul 8, 2014, no change to tracked fieldsv29-v31
  8. Primary and study completion dates pushed to Dec 2016v28
  9. 2 versions Re-verified since Jan 19, 2012, no change to tracked fieldsv26-v27
  10. Study completion date: Dec 2012v25
  11. Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID) to Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
    • Collaborators expanded, about 8 words
    v24
  12. Study sites: 67 to 68v23
  13. Study sites: 66 to 67v22
  14. Trial status: Active, Not Recruiting to Recruiting
    • Study sites: 65 to 66
    v21
  15. Trial status: Recruiting to Active, Not Recruiting
    • Primary completion date: Apr 2005
    • Start date: Mar 2002
    • Site details revised at 65 of 65 sites
    v20
  16. Re-verified, no change to tracked fieldsv19
  17. Site details revised at 2 of 65 sitesv18
  18. Site details revised at 2 of 65 sitesv17
  19. Study sites: 64 to 65v16
  20. Site details revised at 1 of 64 sitesv15
  21. Enrollment target: 50000 to 20000v14
  22. Site details revised at 1 of 64 sitesv13
  23. Site details revised at 1 of 64 sitesv12
  24. Site details revised at 1 of 64 sitesv11
  25. Site details revised at 2 of 64 sitesv10
  26. Site details revised at 1 of 64 sitesv9
  27. Site details revised at 1 of 64 sitesv8
  28. Site details revised at 1 of 64 sitesv7
  29. Site details revised at 1 of 64 sitesv6
  30. Site details revised at 1 of 64 sitesv5
  31. Site details revised at 1 of 64 sitesv4
  32. Site details revised at 1 of 64 sitesv3
  33. Site details revised at 1 of 64 sitesv2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to obtain informed consent to use stored human biological materials (HBM) (e.g., blood and other tissues) for future studies that may include genetic testing.
Trial Details
NCT Number NCT00031408
Lead Sponsor Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
Collaborators: National Institute of Allergy and Infectious Diseases (NIAID)
Conditions
(from sponsor)		 HIV Infections
Related terms HIV Infections
Enrollment 17,444 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov